Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Emerge Weight Loss

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Emerge Weight Loss head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 214 · Grade C

Emerge Weight Loss

Visit Emerge Weight Loss Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 67 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Emerge Weight Loss a bad call — it's best for readers who prefer text-based support and can budget for four-week billing and the price of their prescribed dose. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
77
Transparency
90
72
Access Breadth
93
40
Clinical Oversight
92
85
Track Record
88
73
CoreAge RxBrief Score 94 · 67Emerge Weight Loss

Price, coverage & the tracker

CoreAge RxEmerge Weight Loss
Brief Score94/100 (A)67/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Current quote unconfirmed

The checked pricing focuses on tirzepatide.

Confirm whether semaglutide is offered and obtain a separate complete quote.

Full price details

Current semaglutide offer and complete quote unknown; reviewed pricing focuses on tirzepatide; earlier listing: Not disclosed

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

From $224 every four weeks

Compounded injection; dose-based prices rise to $289 for an existing-patient tier.

Medication, supplies, oversight and shipping advertised as included; oral and maintenance plans are separate.

Full price details

Calendar-month quote unknown; compounded tirzepatide injection starts at $224 per four weeks, rising by dose; 12.5/15 mg tiers for existing patients only; earlier listing: From $287/mo (2.5 mg dose, compounded)

CoverageUS only; restrictions by state, confirmed at intakeDoes not serve California; other state and medication eligibility depends on current pharmacy and regulatory limits
Brand-name accessNot confirmedThe checked program offers compounded tirzepatide; a current branded GLP-1 prescribing offer was not established.
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Emerge Weight Loss: Injectable tirzepatide starts at $224 per four weeks; maintenance is separately $49 per four weeks plus $99 per vial. Oral pricing is a different plan.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.